Komori
Vital Ksk Holdings (3151) · InitiativeRestated

Development of a Pharmacy Supply Chain Model and Expansion Beyond the Group

First written in FY2021. 1 of 2 entries say "Restated". Latest entry: FY2022.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021 – FY20222021: 120212022: 12022
Same theme, other companies
Building and commercializing a pharmacy supply-chain modelA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「In addition to proper inventory management using pharmaceutical dispensing data, we will seek to reduce overall distribution-related costs by combining various functions, including an automated forecasting and ordering function based on prescription information and the use of packaged deliveries that can improve the efficiency of ordering and inspection operations. We will also extend the supply chain model developed through these efforts to customers outside the Group.」

    It continues to pursue a policy of combining inventory management, automated forecasting and ordering, and packaged deliveries in the pharmacy business's supply chain model, with the aim of expanding it outside the Group.
  2. FY2021First statedAnnual report

    「Specifically, in addition to proper inventory management using pharmaceutical dispensing data, we will seek to reduce overall distribution-related costs by combining various functions, including an automated forecasting and ordering function based on prescription information and the use of packaged deliveries that can improve the efficiency of ordering and inspection operations. We will also extend the supply chain model developed through these efforts to customers outside the Group and contribute to the efficient operation of regional healthcare.」

    It newly outlines a measure to build a supply chain combining dispensing data, automated forecasting and ordering, and packaged deliveries across a pharmacy business with approximately 100 stores, and to expand it outside the Group.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Vital Ksk Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development of a Pharmacy Supply Chain Model and Expansion Beyond the Group | VITAL KSK HOLDINGS,INC. (3151) | Komori